Home › Overview of the OMOP Research Program

9 - Reporting

Task: Reporting

All products (including database descriptions, database validations/QA, and analyses) will be published in the peer reviewed literature or be made publicly available in some form at the earliest possible time, in a manner consistent with the OMOP Publication Policy. OMOP will work with its contracted investigators to develop an overall publication strategy, identifying work products and anticipated dissemination venues at the outset, and will modify this plan as needed. Publication responsibilities will ordinarily rest with the investigators, but OMOP will facilitate investigators’ agreement about authorship in advance. Ideally, results will be published in the peer-reviewed literature, but OMOP will reserve the right to public dissemination and ensure this occurs in a timely manner. (See the OMOP Charter for more details - http://omop.fnih.org/?q=node/19).

Common data model: OMOP will make the common data model publicly available via an open source licensing model (such as the LGPL) to ensure that modifications by others also become available.

Database description and validation programs and reporting templates will be made publicly available, possibly under the LGPL or similar licensing provision.

The output of these validation and descriptive analyses will be made publicly available.

  • The simulated database will be made publicly available possibly under the LGPL or similar licensing provision.
  • All protocols (common data model, database validation and characterization, and analyses) will undergo peer review via the OMOP Scientific Advisory Board, or as decided by them. As soon as these protocols have been sufficiently peer reviewed and approved, they will be published on the OMOP website, and comment from the scientific community sought via a listserv or similar online mechanism.
  • All protocols for evaluation studies of drug-outcome pairs will be registered with ClinicalTrials.gov before initiation of the analysis. Hypothesis-generating experiments and other methodological research protocols will also be placed in the public domain in an appropriate location.
  • All results of analyses will be made publicly available in a timely manner.
  • Analytic programs contributed to the conduct of the OMOP pilot and programs developed through OMOP will be made available consistent with the OMOP Intellectual Property Policy, with the aim of respecting the intellectual property of the inventors while preserving the maximum benefit to the public health.